We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Automated Urine Analyzer Offers Fast, Sensitive and Precise AST in Near-Patient Settings

By LabMedica International staff writers
Posted on 26 Apr 2023
Print article
Image: PA-100 AST System (Photo courtesy of Sysmex Europe)
Image: PA-100 AST System (Photo courtesy of Sysmex Europe)

Urinary tract infections (UTIs) are highly prevalent infectious diseases, impacting an estimated 150 million people worldwide. Typically, these infections are treated with antimicrobial drugs. To determine the appropriate medication, healthcare professionals must conduct bacteria identification tests and drug susceptibility tests alongside clinical findings. However, these tests often take days to complete, making it challenging to prescribe the right antimicrobial drugs during the first consultation. Consequently, this can lead to the prescription of improper medications and contribute to the development of antimicrobial resistance.

The PA-100 AST System from Sysmex Europe SE (Norderstedt, Germany) is an innovative automated urine analyzer that expedites antimicrobial susceptibility testing (AST) at the point of care. By combining phase contrast microscopy and nanofluidics, the system generates antibiograms at the point of care. The cutting-edge nanofluidics-based technology ensures exceptional diagnostic performance. User-friendly and efficient, the PA-100 AST System can determine bacterial growth and AST in under an hour, with results conforming to EUCAST standards.

Employing lab-on-a-chip technology, the PA-100 AST System rapidly and automatically analyzes urine samples, optimizing workflow and providing results during a patient's initial visit to the physician. This breakthrough technology brings diagnostics to outpatient clinics, supporting evidence-based medication where extensive antibiotic prescriptions are common. By facilitating antibiotic prescription decisions in less than an hour, the system helps circumvent empirical treatment and curtail the spread of antimicrobial resistance.

Related Links:
Sysmex Europe SE 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.